HCA Healthcare posts Q3 earnings beat, cites $400 M uninsured‑patient hit and lifts full‑year outlook

HCA Healthcare reported third‑quarter 2026 revenue of $19.85 billion, up 3.6% year over year, and adjusted earnings per share of $7.22, beating consensus estimates. The company disclosed an approximately $400 million pretax income reduction caused by a shift toward uninsured patients after changes to health‑insurance exchanges. Despite the hit, HCA raised its full‑year 2026 operating results to the upper half of its previously issued guidance ranges.

The earnings beat and raised guidance suggest stronger near‑term cash flow and may support the recent share repurchase of $2.97 billion, while the $400 million payer‑mix impact signals ongoing headwinds that could affect future profitability.

  • 1Revenue increased 3.6% year over year to $19.85 billion
  • 2Adjusted earnings per share were $7.22, beating the $6.65 consensus by $0.57
  • 3Net income attributable to HCA fell 3.9% to $1.579 billion
  • 4The payer‑mix shift caused an unfavorable pretax impact of approximately $400 million
  • 5Full‑year 2026 revenue guidance remains $77.0 billion to $79.5 billion, with results now expected in the upper half of that range
  • 6HCA repurchased about 7.23 million shares for $2.97 billion during the quarter

Sources